Inogen (INGN) Income from Continuing Operations (2013 - 2026)
Inogen (INGN) posted quarterly Income from Continuing Operations of 8324000.0 for Q1 2026, down 34.82% year-over-year from 12771465.21 in Q1 2025, and down 193.39% quarter-over-quarter from 8913000.0 in Q4 2025.
Inogen (INGN) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Income from Continuing Operations for 14 consecutive years, with 8324000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 34.82% year-over-year to 8324000.0; the TTM figure through Mar 2026 stood at 8857000.0 (up 58.14% YoY), while the FY2025 annual figure was 6707000.0, up 77.31% from the prior year.
- Income from Continuing Operations eased to 8324000.0 in Q1 2026 per INGN's latest filing, from 8913000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 72460000.0 in Q4 2023 and bottomed at 56610000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 7753058.82 across 5 years, with a median of 6174000.0 in 2025.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 1841.8% — and 2025, when it surged 359.55%.
- Inogen's Income from Continuing Operations stood at 56610000.0 in 2022, then surged by 228.0% to 72460000.0 in 2023, then tumbled by 104.74% to 3434000.0 in 2024, then soared by 359.55% to 8913000.0 in 2025, then plunged by 193.39% to 8324000.0 in 2026.
- Business Quant data shows INGN's Income from Continuing Operations at 8324000.0 in Q1 2026, 8913000.0 in Q4 2025, and 5294000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | -3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.85 Mn |
| Mar 31, 2026 | -8.32 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -3.43 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -14.58 Mn |
| Dec 31, 2023 | 72.46 Mn |
| Sep 30, 2023 | -45.72 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | -56.61 Mn |
| Sep 30, 2022 | -9.51 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -22.88 Mn |
| Sep 30, 2021 | 12.17 Mn |